Who is in your network?

BCMA Targeted Therapies Market Research is Expecting to Accrue Strong Growth in Forecast to 2035

The global BCMA targeted therapies market, valued at USD 9.2 billion in 2024, is projected to reach USD 11.8 billion in 2025 and USD 85.9 billion by 2035, representing a CAGR of 21.9% during the forecast period. B-cell maturation antigen (BCMA), an important biomarker of the B-cells, has emerged as a promising therapeutic target for the treatment of multiple myeloma and other hematological malignancies. The antigen is universally expressed on the surface of multiple myeloma cells.

source of information: https://www.rootsanalysis.com/....reports/bcma-targete

Smart Insulin Pens Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035

The global smart insulin pens market is valued at USD 4.31 billion in 2024 and is poised to reach USD 10.36 billion by 2035, representing a CAGR of 8.30% during the forecast period. The report presents these projections with supporting market data, providing a clear reference for understanding current conditions and segment activity.

source of information: https://www.rootsanalysis.com/....reports/smart-insuli

Europe Women’s Digital Health Market Current Impact to Make Big Changes by 2035

The Europe Women’s Digital Health Market report provides a detailed analysis of the current landscape, outlining key insights into business strategies, market trends, and offering both qualitative and quantitative data. This comprehensive report covers critical aspects of the global market, including exploration of key drivers, challenges, growth prospects, and risks. It also presents an in-depth analysis of the competitive environment and regional variations within the Europe Women’s Digital Health industry.

The study outlines key market segments and how they are evolving. It covers a range of important factors impacting the market, such as the introduction of new Europe Women’s Digital Health products, the expansion of market reach by existing companies, and changes in market demand. Strategic movements like mergers, acquisitions, product introductions, and partnerships are explored, offering a comprehensive view of how the market landscape is shifting. The report delivers insightful data on how companies are responding to these changes.

source of information: https://www.rootsanalysis.com/....reports/europe-women

Gene Therapy Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035

Gene Therapy Market Size to Cross $16.5 Billion by 2035 | Exclusive Report by Roots Analysis

The global gene therapy market, valued at USD 2.4 billion in 2024, is estimated to reach USD 3.4 billion in 2025 and USD 16.5 billion by 2035, representing a CAGR of 17.0% during the forecast period.

Gene therapies are a class of biologic products designed to alter the genetic material of an individual to treat rare diseases caused by inherited genetic mutations. These therapies are developed to address the underlying genetic cause of a disease, either by introducing a healthy version of the mutated gene or by inactivating the functions of disease-causing genes within the body. Currently, 20 gene therapies are commercially available for the treatment of various genetic disorders, including spinal muscular atrophy and sickle cell disease. Additionally, more than 370 candidates are currently being evaluated across various phases of clinical trials and around 920 gene therapies are being developed across preclinical and discovery stages of development. Further, it is worth highlighting that these therapies have demonstrated tremendous potential in revolutionizing the treatment of chronic conditions, with promising results in achieving complete disease remission. As such, the demand for gene therapies is increasing substantially, thereby encouraging gene therapy companies and non-industry players to enhance their R&D capabilities in order to develop and advance a greater number of therapies towards the commercial market. Driven by the growing demand for targeted therapies, the gene therapy market size is poised to experience a noteworthy increase during the forecast period.

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/....reports/gene-therapi

Anti-Obesity Drugs Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035

Date of Publication: 2025-Sep-12

The Anti-Obesity Drugs Market report provides a detailed analysis of the current landscape, outlining key insights into business strategies, market trends, and offering both qualitative and quantitative data. This comprehensive report covers critical aspects of the global market, including exploration of key drivers, challenges, growth prospects, and risks. It also presents an in-depth analysis of the competitive environment and regional variations within the Anti-Obesity Drugs industry.

The study outlines key market segments and how they are evolving. It covers a range of important factors impacting the market, such as the introduction of new Anti-Obesity Drugs products, the expansion of market reach by existing companies, and changes in market demand. Strategic movements like mergers, acquisitions, product introductions, and partnerships are explored, offering a comprehensive view of how the market landscape is shifting. The report delivers insightful data on how companies are responding to these changes.

The Anti-Obesity Drugs Market is segmented by several factors, Key Report Attributes, Historical Trends, Forecast Period, Market Size, 2025, Market Size, 2035, CAGR, Type of Molecule, Active Compound Used, Mechanism of Action, Type of Agonist, Action Pathway, Route of Administration, Geographical Regions, Sales Forecast, Key Players, Key Companies Profiled in theAnti-Obesity Drugs Market, Customization Scope, Excel Data Packs(Complimentary).

source of information: https://www.rootsanalysis.com/....reports/anti-obesity